Authors

• Deanna Kornacki (ORCID: https://orcid.org/0000-0001-6286-2069)
• Kim Papp (ORCID: https://orcid.org/0000-0001-9557-3642)
• David Rosmarin (ORCID: https://orcid.org/0000-0003-2786-0708)
• Mark Amster
• Christina Feser
• Jacek Zdybski
• Thierry Passeron (ORCID: https://orcid.org/0000-0002-0797-6570)
• John E. Harris (ORCID: https://orcid.org/0000-0002-7815-6430)
• Khaled Ezzedine (ORCID: https://orcid.org/0000-0002-5468-4589)
• Anthony A. Nuara
• Shaoceng Wei
• Amit G. Pandya (ORCID: https://orcid.org/0000-0002-3916-2651)
• Seth Forman (ORCID: https://orcid.org/0000-0001-5800-1856)
• Haobo Ren

Institutions

• Inserm (FR)
• University of Massachusetts Chan Medical School (US)
• Middle Tennessee State University (US)
• University of Toronto (CA)
• Université Paris-Est Créteil (FR)
• Université Côte d'Azur (FR)
• Saint Thomas - Rutherford Hospital (US)
• Centre Hospitalier Universitaire de Nice (FR)
• Partners In Care (US)
• Probity Medical Research (CA)
• Akademii Nauk Stosowanych im. Józefa Gołuchowskiego (PL)
• Hôpitaux Universitaires Henri-Mondor (FR)
• Vitalant (US)
• Indiana University – Purdue University Indianapolis (US)
• The University of Texas Southwestern Medical Center (US)
• Incyte (United States) (US)

Publication Details

Journal

Dermatology and Therapy

Published

2025-10-22

DOI

https://doi.org/10.1007/s13555-025-01555-3

Citations

3

Primary Topic

melanin and skin pigmentation

Type

article

Field-Weighted Citation Impact

3.45

Funders

• Amgen
• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• GlaxoSmithKline
• Sanofi
• Valeant Pharmaceuticals International
• Dermira
• Incyte
• Celltrion
• Concert Pharmaceuticals
• Horizon Therapeutics
• Kyowa Hakko Kirin
• Meiji Seika Pharma
• Galderma
• Bausch Health
• LEO Pharma